de Brito Marianne, Huebner Gisela, Murrell DedeeF, Bullpitt Peter, Hartmann Karin
1Department of Dermatology, St George Hospital, University of New South Wales, Sydney, Australia.
2Department of Dermatology, University of Luebeck, Luebeck, Germany.
Clin Transl Allergy. 2018 Sep 21;8:37. doi: 10.1186/s13601-018-0222-y. eCollection 2018.
We report two patients with normocomplementaemic urticarial vasculitis with impressive response to omalizumab. This contrasts recent reports on hypocomplementaemic urticarial vasculitis syndrome, highlighting the need for clinical trials of omalizumab in normocomplementaemic urticarial vasculitis.
我们报告了两名患有正常补体血症性荨麻疹性血管炎的患者，他们对奥马珠单抗有显著反应。这与最近关于低补体血症性荨麻疹性血管炎综合征的报告形成对比，突出了对奥马珠单抗在正常补体血症性荨麻疹性血管炎中进行临床试验的必要性。
Zotero 插件